Document is current
Any future updates will be listed below
-
Authors
Sharma, Mitali https://orcid.org/0009-0003-5149-0142
Beaudart, Charlotte
Clark, Patricia
Fujiwara, Saeko
Adachi, Jonathan D.
Papaioannou, Alexandra
Messina, Osvaldo D.
Morin, Suzanne N.
Kohlmeier, Lynn
Nogues, Xavier
Leckie, Carolyn
Harvey, Nicholas C.
Kanis, John A.
Reginster, Jean-Yves
Hiligsmann, Mickael
Silverman, Stuart L.
-
Funding
Funding for this research was provided by:
Amgen
UCB US
Cedars-Sinai Medical Center
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 22 September 2024
First Online: 21 October 2024
Declarations
:
: The whole study was subject to an initial central IRB (Advarra for sites in the USA and Canada) and then local IRB (country and institutional specific) review and approval (if and when required by applicable law). Informed consent was obtained for all phases of the project. All subjects either received a patient information sheet or informed consent depending on the local IRB of the site. Subjects were informed of their ability to withdraw at any time as stated by the coordinator as well as the patient information sheet or informed consent form.
: J.A.K is the founder of FRAX® and Editor-in-Chief of Osteoporosis International; L.K. is an Amgen speaker, Radius consultant, and speaker. Other authors declare that they have no conflict of interest with regard to the content of this manuscript.
